Loading company…
Respiosa develops a minimally invasive implant to treat obstructive sleep apnea.
Respiosa's implant is designed to prevent the tongue from obstructing the airway during sleep. It works with healthcare providers and sleep specialists, primarily in Europe. Founded in 2022 and based in Amsterdam, Netherlands, the company raised GBP 200,000 from PXN Group in December 2025 to support product development and market expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in